Hannah L. Barker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hannah L. Barker has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Llano
NHS Greater Glasgow and Clyde, Glasgow, UK
1 shared publication - Christopher Sainsbury
University of Birmingham, Birmingham, UK
1 shared publication - Deborah Morrison
General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
1 shared publication - Gregory C. Jones
Diabetes Centre, Gartnavel General Hospital, Glasgow, UK
1 shared publication
Latest Publications
- Open Access
- 24 March 2023
- Published by Springer Nature in Diabetes Therapy
- Vol. 14 (5) , 937-945
Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Glucocorticoids, also known as steroids, are a class of anti-inflammatory drugs utilised widely in clinical practice for a variety of conditions. They are associated with a range of side effects including abnormalities of glucose metabolism. Multiple guidelines have been published to illustrate best management of glucocorticoid-induced hyperglycaemia and diabetes in a variety of settings. This article discusses current best clinical practice including diagnosis, investigations and ongoing management of glucocorticoid-induced dysglycaemia in both in- and outpatient settings.
- 24 March 2023
- Published by Springer Nature in Diabetes Therapy
- Vol. 14 (5) , 937-945
Open AccessPractical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Glucocorticoids, also known as steroids, are a class of anti-inflammatory drugs utilised widely in clinical practice for a variety of conditions. They are associated with a range of side effects including abnormalities of glucose metabolism. Multiple guidelines have been published to illustrate best management of glucocorticoid-induced hyperglycaemia and diabetes in a variety of settings. This article discusses current best clinical practice including diagnosis, investigations and ongoing management of glucocorticoid-induced dysglycaemia in both in- and outpatient settings.